| Dr William H Campbell, MD | |
|
1401 S Main St, Ottawa, KS 66067-3528 | |
| (785) 242-4242 | |
| (785) 242-7885 |
| Full Name | Dr William H Campbell |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Location | 1401 S Main St, Ottawa, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033170378 | NPI | - | NPPES |
| B68656 | Other | HUMANA | |
| 461233 | Other | CHILDREN'S MERCY | |
| 33843015 | Other | PHP | |
| P00152754 | Other | RAILROAD MEDICARE | |
| 33843015 | Other | BCBS-KANSAS CITY | |
| 3562421 | Other | AETNA | |
| 103708 | Other | KS | BCBS-KS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 04-13504 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr William H Campbell, MD 1401 S Main St, Ottawa, KS 66067-3528 Ph: (785) 242-4242 | Dr William H Campbell, MD 1401 S Main St, Ottawa, KS 66067-3528 Ph: (785) 242-4242 |
News Archive
The study by Guttmacher Institute researchers found that in 2005 the total number of abortions fell to a total of 1.2 million in 2005, way below the all-time high of 1.6 million abortions in 1990.
A study published in the open access journal BMC Psychiatry suggests that the way in which professional care workers respond emotionally to substance abuse patients with personality disorders depends on the type of disorder.
An imaging study of chronic users of codeine-containing cough syrups (CCS) has found deficits in specific regions of brain white matter and associates these changes with increased impulsivity in CCS users.
A newly discovered group of proteins could help treat cholesterol build-up in arteries. This build-up leads to atherosclerosis or 'hardening of the arteries', and the resulting condition, coronary heart disease, kills an estimated 124,000 each year in England and Wales.
Ingenuity® Systems, the leading provider of information solutions for life science researchers, today announced the release of the white paper, "Best Practices for Assessing Toxicity throughout the Drug Discovery Process: Toxicogenomics." The white paper is based on input from industry experts and shows how multidisciplinary toxicology teams in drug discovery can leverage toxicogenomics and IPA® for improved predictive toxicology and mechanistic toxicity analysis.
› Verified 1 days ago
Dr. Kenneth J Frank, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1401 S Main St, Ottawa, KS 66067 Phone: 785-242-4242 Fax: 785-242-7885 |